Three separate statistical teams analyzed data from the Age-Related Eye Disease Study and found no evidence that genotyping can guide chemoprevention of age-related macular degeneration.
The three teams analyzed AREDS participants with AMD worse than category 1 and who had genotyping data. One team focused on data concordance between conflicting studies, a second focused on repeating claims of interactions between genotype and treatment, and a third attempted to find baseline predictors of treatment response.
Genotype data were analyzed for three single nucleotide polymorphism (SNP) locations
Uncategorized